Ketamine policy and procedure


    • MEDICATION MANUAL Policy and Procedure

      Policy and Procedure This is a CONTROLLED document for internal use only. Any documents appearing in paper form are not controlled and should be checked against the electronic file version prior to use. TITLE: Ketamine for Adjunct Analgesia, Care of a Patient Receiving A Continuous IV Infusion of NUMBER: MM-MS-001


    • [PDF File]Ketalar (Ketamine) and Spravato (Esketamine)

      https://info.5y1.org/ketamine-policy-and-procedure_1_361634.html

      Medical Benefit Drug Policy Ketalar® (Ketamine) ... The following list(s) of procedure and/or diagnosis codes is provided for reference purposes only and may not be all inclusive. Listing of a code in this policy does not imply that the service described by the code is a covered or non-covered health service.


    • [PDF File]ACEP Ketamine Guideline 2011 - emupdates

      https://info.5y1.org/ketamine-policy-and-procedure_1_8f43c1.html

      Characteristics of the Ketamine “Dissociative State” Detailed descriptions of the unique clinical manifestations of ketamine are beyond the scope of this guideline, and interested readers are referred to other sources.4,12,15,16,23 Indications The literature is strongly supportive of the safety and efficacy


    • [PDF File]Protocol for the Use of IM Ketamine for Children

      https://info.5y1.org/ketamine-policy-and-procedure_1_e54ad3.html

      Procedure ♦ Ketamine checklist to be completed contemporaneously. ♦ Ketamine and atropine are administered intramuscularly, with the child held in parent/carer’s arms, where possible. ♦ Once sedated, child is placed on the trolley and pulse and oxygen saturation monitored continuously. ♦ Position the child during the procedure to obtain an optimal airway patency.


    • [PDF File]ANESTHESIOLOGY POLICIES AND PROCEDURES

      https://info.5y1.org/ketamine-policy-and-procedure_1_bc5ca6.html

      st francis medical center anesthesiology policies and procedures approved by: brian hacker, m.d. chief of anesthesia services chief’s signature, sfmc april 2017 all policies and procedures in this manual were reviewed and revised as needed in april 2017.


    • POLICIES AND PROCEDURE MANUAL

      department requiring/authoring the policy. 2. Exhibit – a supporting document developed and maintained in a department other than 3. the department requiring/authoring the policy. 4. Devised – the date the policy was implemented. 5. Revised – the date of every revision to the policy, including typographical and grammatical changes. 6.


    • CLINICAL ALGORITHM FOR KETAMINE ADMINISTRATION FOR ...

      Ketamine administration for depression will follow UHS guidelines for Moderate Sedation/Analgesia (Conscious Sedation), Policy No: 9.12 (effective Date: 04/03/12). Under this guideline, Conscious Sedation is defined as a drug-induced depression of consciousness during


    • [PDF File]Ketamine for Treatment of Psychiatric Disorders and Pain ...

      https://info.5y1.org/ketamine-policy-and-procedure_1_a24dd8.html

      Ketamine hydrochloride is also increasingly being used for chronic pain management. Use of Ketamine for the treatment of psychiatric disorders and for chronic pain management is an off label use and not an FDA-approved treatment. POLICY Ketamine (J3490) to treat any psychiatric disorders, chronic pain, or migraine headaches is non-covered.


    • [PDF File]Administration of IV Anesthetic Agent Ketamine for ...

      https://info.5y1.org/ketamine-policy-and-procedure_1_3026ba.html

      STRONG MEMORIAL HOSPITAL POLICY MANUAL SECTION #8 GENERAL PATIENT CARE DATE 5-10 8.11.3 Administration of IV Anesthetic Agent Ketamine for Inpatient Treatment of Intractable Pain PAGE 1 of 3 P O L I C Y Ketamine is an anesthetic with analgesic, sedative, amnesic and dissociative properties.


    • [PDF File]Ketamine Infusions for Outpatient Pain Management

      https://info.5y1.org/ketamine-policy-and-procedure_1_06822e.html

      care facilities need to have a policy in place that guides patient care for this procedure. Literature Review Much of the literature on ketamine infusions for pain management does not distinguish inpatient from out-patient use. Common themes in the literature on the use of ketamine have included its potential to cause a


    • [PDF File]Medical Policy Intravenous Ketamine for Treatment ...

      https://info.5y1.org/ketamine-policy-and-procedure_1_0fdb23.html

      authorization for the procedure. Administration of IV ketamine is considered investigational in all other situations. Ketamine is an antagonist of the N-methyl-D-aspartate receptor and a dissociative anesthetic. There are two main types of ketamine used to treat treatment-resistant major depression. Racemic ketamine, which


    • [PDF File]GUIDELINES FOR USING KETAMINE

      https://info.5y1.org/ketamine-policy-and-procedure_1_160001.html

      Movement or procedure related pain. E.g painful dressing changes or pathological fractures Dose 2.5mg- 5mg of ketamine oral solution 50mg/5ml Sublingual ketamine has a rapid onset peak blood level (similar to parenteral ketamine), therefore it may be useful for rapid analgesic effect.


    • [PDF File]Ketamine infusions for adult patients for acute and ...

      https://info.5y1.org/ketamine-policy-and-procedure_1_3d88c2.html

      Ketamine is a Schedule 8 drug under the Poisons and Therapeutic Goods Act. Ketamine is compatible, as a separate infusion via a Y site, with fentanyl, morphine sulphate and hydromorphone. Ketamine can produce severe dysphoric and hallucinogenic sensations/reactions. For this


    • [PDF File]Ketamine Infusion Chart (adult) Explanatory Notes

      https://info.5y1.org/ketamine-policy-and-procedure_1_886e72.html

      Management guidelines are printed on the ‘fold out’ front page of the Ketamine Infusion chart. Users should refer to their own hospital’s ketamine infusion policy or procedure for detailed information relating to ketamine prescribing and management. The Management Guidelines are summarised in point form: o Frequency of observations


    • [PDF File]GUIDELINES FOR SAFE ADMINISTRATION OF LOW-DOSE KETAMINE K

      https://info.5y1.org/ketamine-policy-and-procedure_1_17abe3.html

      ketamine infusion rates do not differ between inpatient and outpatient settings. When ketamine administration in the home or hospice setting is considered, the most commonly studied treatment method for pain management is through a continuous low-dose intravenous or subcutaneous infusion. Administration rates of 0.05 - 0.5 mg/kg/hour


    • [PDF File]Michigan Medicine Ketamine IV Continuous Infusion ...

      https://info.5y1.org/ketamine-policy-and-procedure_1_909d20.html

      Half-Life: Ketamine = 5-17 minutes, norketamine = 180-300 minutes Pharmacodynamics Ketamine primarily acts as an antagonist to the NMDA receptor, although it also has some antagonistic effects of delta, kappa, and mu receptors as well. Ketamine also inhibits re-uptake of catecholamines, which can yield an increase in blood pressure. Considerations


    • [PDF File]Guidelines for Ketamine Use

      https://info.5y1.org/ketamine-policy-and-procedure_1_d0e746.html

      Guidelines for Ketamine Use Ketamine is a dissociative anaesthetic agent which has analgesic properties in sub-anaesthetic doses 1 Its principal site of action is in the dorsal horn of the spinal cord where it blocks the N-methyl D-aspartate (NMDA) receptor complex.


    • [PDF File]Spravato® (Esketamine) – Oxford Clinical Policy

      https://info.5y1.org/ketamine-policy-and-procedure_1_7debfc.html

      This policy refers to the following ketamine products: Spravato (esketamine) ... for a procedure 20such as electroconvulsive therapy (ECT) or transcranial magnetic stimulation (TMS). Spravato (esketamine) is the S-enantiomer of racemic ketamine, and is a non-selective, non-competitive antagonist of the N-


Nearby & related entries: